Literature DB >> 32423691

Molecular basis of unilateral condylar hyperplasia?

J W Nolte1, M Alders2, L H E Karssemakers3, A G Becking4, R C M Hennekam5.   

Abstract

Unilateral condylar hyperplasia (UCH) causes progressive asymmetry of the mandible. The aetiology of this growth disorder is unknown. A two-centre prospective study was established, and 10 consecutive adult UCH patients scheduled for high condylectomy were included. The resected condylar tissue was divided into two parts, one for regular histopathology and one for DNA extraction. A panel of eight selected overgrowth genes (AKT1, AKT3, MTOR, PIK3CA, PIK3R2, PTEN, TSC1, TSC2) were sequenced using next-generation sequencing, with coverage of a minimum 500 times in order to be able to detect low-grade mosaicisms. Subsequently, untargeted whole exome sequencing (WES) was performed to detect variants in other genes present in three or more patients. No mutation was detected in any of the overgrowth genes, and untargeted exome sequencing failed to detect any definitively causative variant in any other gene. Ten genes had a rare variant in three or more patients, but these cannot be designated as causative without additional functional studies. The hypothesis that the cause in at least some patients with UCH is a somatic mutation in a gene that controls cell growth could not be confirmed in this study.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  condylar hyperplasia; genetics; hemimandibular elongation; hemimandibular hyperplasia; mandibular asymmetry; maxillofacial surgery; unilateral condylar hyperactivity; unilateral condylar hyperplasia

Year:  2020        PMID: 32423691     DOI: 10.1016/j.ijom.2020.01.017

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  1 in total

1.  Growth trends analysis of unilateral condylar hyperplasia followed up with planar scintigraphy: Retrospective overview of 249 cases.

Authors:  Pingan Liu; Jun Shi
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.